|
Futura Medical Announces Positive Phase I Results for PET500
PharmaLive.com (press release), PA - Dec 9, 2008 … is pleased to announce positive results from its Phase I study of PET500, the Company’s innovative treatment for premature ejaculation. … |
|
Premature Ejaculation: Secrets Revealed
Search By Headlines (press release), NV - Nov 10, 2008 The most common sexual dysfunction in men younger than 40 years is premature ejaculation (PE). Premature ejaculation is defined as a condition when the … |
|
Best Way To Wow Your Woman
Search By Headlines (press release), NV - 4 hours ago At least a third of men surveyed in the United States in a 1999 report at least one incidence of premature ejaculation in the previous year. … |
 Business Wire (press release) |
Sciele Pharma and Plethora Solutions Announce Positive Phase III …
Business Wire (press release), CA - Nov 7, 2008 There are currently no approved pharmaceutical treatments for premature ejaculation. PSD502 is applied locally "on demand" and is effective within five … Plethora: Plethora reports positive outcomes of European Phase III … Proactive Investors UK all 14 news articles |
|
Plethora premature ejaculation drug meets goals
Reuters UK, UK - Nov 6, 2008 L: Quote, Profile, Research) said on Friday its premature ejaculation drug has met all of its goals in a phase III trial. The company said PSD502, … Sciele Pharma and Plethora Solutions Announce Positive Phase III … Business Wire (press release) Plethora: Plethora reports positive outcomes of European Phase III … Proactive Investors UK Plethora hits target in European trial ShareCast Hemscott - GrowthBusiness.co.uk all 14 news articles |